HMMR and cancer: Hyaluronan-mediated motility receptor (RHAMM), also known as CD168, is an HA-binding protein and has been implicated in mitotic spindle formation/stability, correlated with poor outcomes in many cancers [51–54], and is implicated in metastasis [55, 56].